Literature DB >> 21348622

Seroprevalence of Angiostrongylus cantonensis infection in humans in China.

Mu-Xin Chen1, Ren-Li Zhang, Lin Ai, Jia-Xu Chen, Shao-Hong Chen, Da-Na Huang, Shi-Tong Gao, Yi-Jie Geng, Xiao-Heng Li, Xing-Quan Zhu.   

Abstract

A seroepidemiological survey was carried out in China during 2009-2010 to determine the extent of circulating antigens (CAg) for Angiostrongylus cantonensis in the Chinese population using the gold immunochromatographic assay, with the objective of elucidating the nationwide prevalence of angiostrongyliasis in China. A total of 1,730 blood samples was collected and assayed from the general adult population (the "general group"), and those involved in aquaculture or processing of snails Achatina fulica and Pomacea canaliculat (the "occupational group") from 5 provinces (Fujian, Hunan, Guangdong, Guangxi, and Zhejiang) and 1 municipal city (Beijing). The overall seroprevalence for the "occupational group" was 7.4% (40/540), which was significantly higher (P < 0.001) than that of the "general group" (0.8%, 9/1,190). The seroprevalence in males (9.5%) was significantly higher than in females (4.2%) (P < 0.05). These results demonstrate that angiostrongyliasis represents a significant zoonotic disease in China, requiring the strengthening of food safety for control of this food-borne disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21348622     DOI: 10.1645/GE-2614.1

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  2 in total

Review 1.  Current status and challenge of Human Parasitology teaching in China.

Authors:  Hong-Juan Peng; Chao Zhang; Chun-Mei Wang; Xiao-Guang Chen
Journal:  Pathog Glob Health       Date:  2012-11       Impact factor: 2.894

2.  Diverse gastropod hosts of Angiostrongylus cantonensis, the rat lungworm, globally and with a focus on the Hawaiian Islands.

Authors:  Jaynee R Kim; Kenneth A Hayes; Norine W Yeung; Robert H Cowie
Journal:  PLoS One       Date:  2014-05-02       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.